Clene, Inc. (CLNN)
3.85
-0.14
(-3.63%)
USD |
NASDAQ |
Sep 04, 16:00
3.85
0.00 (0.00%)
Pre-Market: 20:00
Clene SG&A Expense (TTM) : 7.873M for June 30, 2026
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 7.873M |
| March 31, 2026 | 8.32M |
| December 31, 2025 | 9.229M |
| September 30, 2025 | 10.34M |
| June 30, 2025 | 11.61M |
| March 31, 2025 | 12.54M |
| December 31, 2024 | 13.31M |
| September 30, 2024 | 13.54M |
| June 30, 2024 | 13.79M |
| March 31, 2024 | 14.40M |
| December 31, 2023 | 14.42M |
| September 30, 2023 | 15.16M |
| June 30, 2023 | 15.05M |
| March 31, 2023 | 15.59M |
| December 31, 2022 | 16.94M |
| September 30, 2022 | 18.06M |
| June 30, 2022 | 18.91M |
| March 31, 2022 | 21.39M |
| Date | Value |
|---|---|
| December 31, 2021 | 22.00M |
| September 30, 2021 | 16.74M |
| June 30, 2021 | 14.13M |
| March 31, 2021 | 8.201M |
| December 31, 2020 | 3.623M |
| September 30, 2020 | 3.863M |
| June 30, 2020 | 2.218M |
| March 31, 2020 | 1.308M |
| December 31, 2019 | 0.5883M |
| September 30, 2019 | 0.546M |
| June 30, 2019 | 0.4688M |
| March 31, 2019 | 0.3784M |
| December 31, 2018 | 0.3239M |
| September 30, 2018 | 0.1266M |
| June 30, 2018 | 0.0538M |
| March 31, 2018 | 0.0382M |
| December 31, 2017 | 0.00 |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| NovelStem International Corp. | 0.1201M |
| Brainstorm Cell Therapeutics, Inc. | 6.474M |
| Summit Therapeutics, Inc. | 306.10M |
| Kezar Life Sciences, Inc. | 18.27M |
| Protara Therapeutics, Inc. | 23.56M |